Down-regulation of retroviral vector expression occurs in a number of cell types after transplantation. Although a num-
Introduction
Silencing of retroviral transcription is a well-documented phenomenon in a wide variety of cell types and numerous viral strains (reviewed in Ref. 1) . While transcriptional shutdown may be a normal component of retroviral biology, it is also a significant hurdle to be overcome for long-term gene expression for retroviral gene delivery systems (reviewed in Ref. 2) . The mechanisms responsible for retroviral transcriptional shutdown are not fully understood and studies show considerable diversity of effect on expression with different variables. The virus type, target cell type, transferred foreign sequence, and selectable marker genes have all been found to affect the degree of silencing. For example, in fibroblasts a retroviral vector encoding adenosine deaminase (ADA) exhibits complete transcriptional shutdown, 3 whereas a similar vector encoding the lysosomal enzyme glucocerebrosidase demonstrates a high level of expression. 4 When the target cell type for the ADA vector is skin fibroblasts gene expression is shut down, however, the same vector maintains high levels of expression in vascular endothelial cells. 5 Several vector designs expressing the lysosomal enzyme ␤-glucuronidase (GUSB) are down-regulated in most cells, but consistently maintain expression in a small subset (1-5%) in both fibroblasts and hematopoietic cells. [6] [7] [8] [9] [10] [11] [12] The presence of the selectable marker sequence, bacterial neomycin resistance gene (neo), has produced inconsistent effects on retroviral vector expression. In some experiments neo appears to inhibit expression, 13, 14 whereas in other experiments it does not. 12, 15 In the Moloney murine leukemia virus (Mo-MuLV), a number of regulatory elements have been found to influence transcriptional down-regulation of viral genes from the LTR. These include the enhancer repeat unit, 16, 17 the negatively acting cis element in the upstream conserved region (UCR) that binds the YY1 transcription factor, 18, 19 and the primer binding site (PBS). 17, 20, 21 Methylation of cytosine bases in vector sequences has been associated with the observed transcriptional down-regulation. [22] [23] [24] [25] However, the precise role of methylation in mediating the repression of gene expression is not clear.
ing cells persist for long periods after transplantation. In this study we found that deletion of all the transcriptional regulatory elements from the vector LTR, inclusion of a permissive primer binding site sequence, and use of a eukaryotic housekeeping promoter could greatly increase the number of expressing cells in fibroblast grafts in subcutaneous neo
In the present study, we used the GUSB-negative mouse model 26 to examine the effects of viral vector modifications on expression of a GUSB cDNA in vivo. Since vector down-regulation occurs after cells have been transplanted in vivo, the effects of vector modifications were studied quantitatively using a procedure that allows recovery of grafts and single cell analysis of explanted cells. 8 We found that the down-regulation could be overcome by completely removing all of the known regulatory elements in the LTR, using a permissive PBS sequence, and using an ubiquitously expressed eukaryotic promoter. The presence of a neo expression cassette driven by a eukaryotic promoter did not have a negative effect. There were significantly increased percentages of transduced cells that expressed GUSB at times when vectors with less extensive modifications were down-regulated. Furthermore, this vector expressed five-fold higher levels of GUSB enzymatic activity per positive cell, showing that the deleted regulatory elements were also mediating a negative effect on expression levels even in cells where expression was not extinguished. This resulted in more than a 50-fold increase in total activity compared with the previous highest expressing vector.
Results
We have shown previously that low levels of GUSB expression from retroviral vector transduced cells can effectively correct lysosomal storage disease in major organs in the MPS VII mouse 10, 11 and dog. 12 Most of the transduced cells become negative for expression by 1-4 weeks after transplantation. However, a low percentage (Ͻ5%) of cells consistently continue to express the transferred gene using various promoters and vector configurations. 8, [10] [11] [12] We transduced fibroblasts with altered retroviral vectors which contained modifications that might affect expression (Figure 1 ). Two vectors without selectable markers were used. The MFG-␤G vector uses the LTR promoter to express the GUSB cDNA from the start codon of the spliced viral envelope gene, and has no selectable marker. 9, 12, 24 The Glu-3 vector contains a deleted enhancer section of the 3' LTR and has GUSB expressed from an internal PGK promoter. 9 Vectors with a selectable marker included LBGSN which is the LXSN vector 27 with the GUSB transcriptional unit inserted upstream of the neomycin resistance gene. 12 The L YY1 BGSN vector is identical to LBGSN except that the YY1 negative regulatory element (also known as NF-kb) in the UCR of the LTR was changed to a non-binding sequence. 28 An established mouse MPS VII fibroblast cell line (3521 cells) derived from this strain of mouse was used for the experiments. 26 The 3521 cells were transduced and selec- ted with G418 or, for vectors with neo, transduced without high titer vectors to obtain a population of cells greater than 95% positive. Transduced cells were transplanted into the brains of MPS VII mice, and assayed at 1, 3 and 6 weeks after transplantation to span the period in which down-regulation typically occurs (1-4 weeks) with retroviral vectors. 8, 10 Histochemical staining of representative brain sections through the grafts transduced with the MFG-␤G, Glu-3, or L YY1 BGSN vector showed that the number of GUSB-positive cells was greatly decreased by the 6-week time-point (Figure 2 ). Since the number of positive cells varied by section, brain sections spanning the engrafted area were pooled and analyzed quantitatively for GUSB enzymatic activity to obtain representative amounts of expression (Table 1 ). By the 6 week time-point, expression levels for all three vectors had dropped to р0.5% of their levels at 1 week. This degree of reduction in expression was comparable to that reported previously for other GUSB retroviral vectors. 6, 8, 10, 11 We have shown that the loss of expression occurs in viable fibroblast grafts, assessed by fibronectin expression from the engrafted cells. 10 To determine whether the negative regulatory effects on GUSB expression were due to retroviral sequences, or to negative elements within the transcriptional unit, we transfected MPS VII fibroblast cells with a DNA fragment containing the GUSB cDNA expressed from its own promoter plus a polyA signal sequence (XGUSB) (Figure 1 ) into MPS VII cells. A control group of cells was transfected with the linearized pUC18 plasmid containing this GUSB expression unit (pGUSB) thus the integrated transcription unit was flanked by bacterial plasmid sequence ( Figure 1 ). Each DNA element was co-transfected with pSV2neo on a separate plasmid into 3521 cells, which Gene Therapy were selected with G418. The neo gene was transfected on a separate plasmid to reduce potential cis-acting effects on the expression of the transfected GUSB sequence. Since the plasmids were cut with different restriction enzymes that did not have overlapping sequences, it is less likely that concatemers between the neo and GUSB plasmids may have formed. However, this also resulted in selecting some GUSB-negative cells that were positive for neomycin resistance. Lipofectamine transfection was used to obtain greater than 1000 independent colonies for each construct. The large number of stable transfectants was chosen in order to obtain a large set of random stable integration sites, to average out potential influences of positional effects, similar to that which occurs with retrovirus vector infection. For these studies, we used a neo-organ transplantation system because the cells can be recovered from the graft and grown in explant cultures, which allows quantitative analysis for both percentage of positive cells and GUSB enzymatic activity. 8 The modified fibroblasts were transplanted in a matrix of collagen and non-absorbable polytetrafluoroethylene (PTFE) fibers (GoreTexTM). 9 Our previous results demonstrated that explanted cells retain expression patterns established in vivo. 8 Neo-organs were constructed using transfected or transduced fibroblasts and implanted subcutaneously into adult MPS VII mice (four independent neo-organs per mouse). The neoorgans were removed from the mice at various times after transplantation and assayed for GUSB enzymatic activity.
Figure 2 Transduced MPS VII fibroblast grafts in brains of MPS VII mice. Representative sections are shown. 3521 cells were transduced with MFG-␤G (a-c), Glu-3 (d-f), L YY1 BGSN (g-i), or L⌬4pQ-H␤H (j-l). Grafts were assayed after 1 (a, d, g, j), 3 (b, e, h), 4 (k), 6 (c, f, i), or 8 (l) weeks after transplantation. All photomicrographs were taken using differential interference microscopy (Nomarski
After removal, part of each neo-organ was prepared for histochemical staining (Figure 3) . The transfected cells that contained either the expression plasmid or just the DNA fragment of the transcription unit showed high levels of GUSB expression at 6 weeks (Figure 3a-d) . Since 3521 cells transduced with retrovirus vectors were downregulated by this time, this result indicated that elements within the viral backbone were mediating the silencing. Since the individual changes made to known negative regulatory elements had little effect on vector silencing (Figure 2a-i) , we next removed all of the transcriptional regulatory elements from the LTR of the retroviral vector (named L⌬4pQ-H␤H, Figure 1 ). In addition, a permissive primer binding site (PBS) was used, originally described in the dl58rev vector 29 and used in the MSCV and MND vectors. 24, [30] [31] [32] In comparison to the L YY1 BGSN vector, where the YY1 site was altered to a non-binding sequence, in the L⌬4pQ-H␤H vector, the YY1 binding site was removed as were the G/C repeat unit and the promoter and enhancer elements. Although the LTR deletion was made up to the U3/R junction, the end filling and blunt end ligation restored the complete R1 region, thus infectious vector virus was produced by the packaging cells (titer у10 5 ). MPS VII fibroblasts were transduced with L⌬4pQ-H␤H, selected with G418, and neo-organs were constructed and transplanted. The mice were killed at 1, 3, 6 and 10 weeks, and the neo-organs were prepared for histochemical staining (Figure 3e-g ) and explantation (Figure 3h-k) . The explanted cells were evaluated with a quantitative enzyme assay for GUSB enzymatic activity, and the percentage of GUSB-positive cells was determined using identical conditions that we previously have shown reflect the numbers of positive cells in vivo. 8 The fibroblasts transduced with L⌬4pQ-H␤H vector conGene Therapy tinued to produce GUSB at very high levels (Figure 3h k) at the later time-points compared with the down-regulation seen with the fibroblasts transduced with DC-H␤H (Figure 3m, n) . In the primary grafts of L⌬4pQ-H␤H, the percentage of GUSB-positive cells was 32 times greater than for primary transplants of DC-H␤H fibroblasts (Table 2) , and the level of GUSB activity expressed by these cells was 58 times higher (Table 2) .
In previous experiments, we showed that transduced fibroblasts in neo-organs could be explanted into cell culture, and that the small population of vector-expressing cells could be selected, expanded and re-implanted as secondary grafts. 8 The small percentage of positive cells selected from the primary grafts after down-regulation occurred (Figure 3n ), continued to express GUSB in the secondary grafts after re-transplantation (Figure 3o ), thus representing stable clones. The percentage of positive cells in the L⌬4pQ-H␤H primary grafts at 10 weeks (Figure 3k ), was the same as the DC-H␤H cells in the secondary grafts, after selection for stable high expressors 8 ( Table 2) . With the same percentage of positive cells, the level of GUSB activity expressed by L⌬4pQ-H␤H primary fibroblasts was five times greater than from the secondary grafts of DC-H␤H-transduced cells (Table 2 ). In addition, the level of expression remained stable after 6 weeks ( Table 2) .
Some of the decrease in GUSB enzymatic activity during the first 6 weeks for L⌬4pQ-H␤ H fibroblasts may be attributed to the process of graft consolidation and cell turnover. 8, 9 Since the 3521 cells are syngeneic with the transplant host, the explanted cell population contains three types of cells: (1) transduced fibroblasts that continue to express GUSB; (2) transduced fibroblasts that have undergone retroviral transcriptional shutdown; and (3) host cells that grow into the graft that are GUSB-negative and were never transduced. To determine the relative amounts of vector-containing cells in the grafts independent of expression, we compared explanted cell populations using real-time quantitative PCR. The GADPH gene was used as a control since it is present as a single copy gene. The ratio between GUSB and GADPH threshold cycles was used to evaluate the relative amounts of provirus positive cells in the explant population. Based on these ratios, there was not a significant variation in the proportion of provirus containing cells in any sample set, although there were small differences among individual grafts (Table 3) . Thus, the low expression levels in some grafts were not a result of higher loss of vector-containing cells.
Since the neo-organ grafts include variable amounts of non-transduced host cells, to determine if a high percentage of L⌬4pQ-H␤H-transduced cells remained positive we transplanted them into the brain, where the cells remain primarily at the site of injection. 10 GUSB-positive cells were present throughout the graft for at least 8 weeks (Figure 2l, n) . The brain grafts showed extensive GUSB expression at time-points when DC-H␤H had already down-regulated expression. 10 In contrast, the other vectors with single modifications demonstrated a significant decrease in GUSB expression between the 3-and 6-week time-points (Figure 2a-k) . At 8 weeks after transplantation, the L⌬4pQ-H␤H grafts expressed 8% of the amount at 1 week, compared with less than 1% of the 1-week values for the other vectors at 6 weeks after transplantation. 8 These experiments were done contemporaneously.
Figure 3 GUSB expression in transplanted neo-organs and explanted cells. Representative cryo-sections of whole neo-organs (a-g) are shown from 3521 cells transfected with pGUSB (a, 3 weeks; b, 6 weeks) or XGUSB (c, 3 weeks; d, 6 weeks), or infected with L⌬4pQ-H␤H (e-g, 3, 6 and 10 weeks, respectively). Explanted cells are from L⌬4pQ-H␤H neo-organs at 1 (h), 3 (i), 6 (j), and 10 (k) weeks post-transplant. Control cells are uninfected 3521 cells (l), DCH␤H transduced and G418-selected in vitro (m), DCH␤H cells after shut-down (n), and DCH␤H-positive cells 10 weeks after secondary transplant (o). All photomicrographs were taken using differential interference microscopy (Nomarski). GUSB-positive cells are indicated by bright red staining. The size bar represents 500 m in (a-g) and 100 m in (h-o).

Discussion
In this study, we found that removal of all the transcriptional regulatory elements from the LTR, in combination with a permissive PBS sequence and a universally expressed eukaryotic promoter, can circumvent retroviral vector shutdown. The results from the plasmid transfection experiment suggest that it is the viral flanking sequences that mediate the silencing of gene expression. The finding of sustained expression with the L⌬4pQ-H␤H vector compared with those with less extensive modifications indicates that several retroviral sequences work together to mediate shutdown. The MND vector is also based on Mo-MuLV, is permissive for expression in most cells, and also contains multiple alterations. 24, 32 The PBS is the permissive sequence found in the dl58rev vector, the YY1 region was deleted, the enhancer was deleted, and Thy-1, a positive regulatory element reported to decrease methylation, was added to the LTR. In comparison, in L⌬4pQ-H␤H the dl58rev permissive PBS is also used, but the entire segment of the YY1, G/C repeats, enhancer and promoter of the LTR were deleted. Among other modified vectors that continue to be down-regulated, in the DC-H␤H vector the YY1 site was disrupted 33 and in the Glu-3 vectors only the enhancer element was deleted. 9 Loss of expression occurred with both the MFG and Glu-3 vectors despite the fact that neither contains a bacterial selectable marker gene. Moreover, the Glu-3 vector expresses the GUSB cDNA from the eukaryotic PGK pro- moter. Although evidence has been found that non-mammalian selectable markers are targets for down-regulation, no direct mechanism of down-regulation by these sequences has been shown. Our data indicate that the neomycin resistance gene was not involved. The data indicate that the majority of position-dependent negative regulatory elements have been removed from the vector. This is further supported by data (not shown) that the modified vector expressed GUSB at similar levels and lengths of time when the transcription unit was inserted in reverse orientation. The percentage of GUSB-positive cells was comparable between primary grafts of L⌬4pQ-H␤H transduced fibroblasts and the DC-H␤H transduced fibroblasts in secondary grafts after selection for stable in vivo expression. Furthermore, GUSB expression on a per cell basis was significantly higher in the L⌬4pQ-H␤H-transduced cells. Since there is a proportional relationship between mRNA levels and the amounts of intracellular and of secreted GUSB activity, 33 the deleted sequences appear to exert a negative transcriptional effect on expression of the GUSB cDNA in those cells in which transcription has not been silenced. The deletion in the LTR could also accommodate additional positive regulatory elements since large inserts in this location have been shown to be replicated.
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Materials and methods
Vectors
The structures of the vectors used are shown in Figure 1 . The MFG-BG, Glu-3, DC-H␤H and LBGSN vectors have been described previously. 9, 12, 33 Additional vectors were produced with modifications to the 3'LTR.
The vector L YY1 BGSN (Figure 1 ) was a modification of Gene Therapy LBGSN (described in Ref. 12). The LBGSN was made from the LXSN 27 by cloning the human GUSB cDNA into the XhoI site. The YY1 motif in the UCR of the LTR was modified to a non-binding sequence. To do this, a 943 bp fragment containing the 3'LTR of the LNSX vector 27 was isolated with HindIII and NdeI, end filled, and blunt end ligated into the HincII site of Bluescript KS (Stratagene, La Jolla, CA, USA). Using PCR-mediated site-directed mutagenesis, the sequence that contains the YY1 core binding domain (sequence underlined) (AA CGCCATTTTGCAA) 19 was changed to (CGACTA GTCGACAATAGC). This modified LTR was substituted for the 3'LTR of the LBGSN vector in the plasmid. This vector generated a YY1 mutated provirus in target cells since the 3' LTR is used as a template for both the 5' and the 3'LTRs in the target cell.
A new retrovirus vector, L⌬4pQ-H␤H, was made by removing all of the viral elements known to affect transcription from the LTR and using a permissive primer binding sequence (PBS). 35 The 3'LTR that was used to make the L YY1 BGSN vector had a SalI site introduced when making the YY1 mutation (sequence underlined) (CGACTAGTCGACAATAGC). The whole region of the LTR containing the YY1, G/C repeats, enhancer, and promoter was deleted by digestion with SalI and NarI (which cuts at the 5' end of the R region). The plasmid was endfilled, which restored the complete R sequence, and ligated. The LTR with the deleted region (⌬3'LTR) was then excised from the cloning vector using the restriction enzymes XbaI and XhoI, end-filled, and used to replace the 3' end of MSCVneoEB vector 31 (a gift from R Hawley, Ontario Cancer Center, Toronto, Canada), which had previously been removed with ClaI (in the retrovirus sequence) and AflIII (in the pUC18 sequence). This created a vector containing the ⌬3'LTR, as well as the For plasmid expression vectors, the same 2.6-kb human GUSB transcription unit (H␤H) that was used in the L⌬4pQ-H␤H was cloned into pUC18 upstream of the SV-40 polyA sequence. The plasmid DNA was linearized by cutting in the middle of the bacterial sequence with the restriction enzyme ScaI and named pGUSB. A DNA fragment containing just the GUSB transcription unit, composed of the human GUSB promoter, human GUSB cDNA and the polyA signal was isolated as a 3.1 kb EcoRI-HindIII fragment, designated X-GUSB. The pSV2neo expression plasmid for co-transfection was linearized with the restriction enzyme XmnI.
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Cells and tissue culture Fibroblasts were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal calf serum, 50 nM 2-mercaptoethanol, 100 units/ml penicillin, 0.05 M streptomycin, and 2.0 mM glutamine. The 3521 cells, a murine fibroblast cell line immortalized by serial passage, was transduced with the retroviral expression vectors as previously described. 8, 10, 33 All cultures were maintained at 37°C in 5% CO 2 . Serum was heat-inactivated at 65°C for 60 min to inactivate bovine ␤-glucuronidase. The retroviral vectors were converted into amphotropic viruses in GP+envAM12 packaging cells, 38 which were cultured in DMEM containing 10% FBS.
Transfection and transduction
The mini gene (X-GUSB) or the bacterial plasmid with GUSB cDNA (pGUSB), was co-transfected with pSV2neo at a 10:1 ratio of GUSB vector to pSV2neo into immortalized MPS VII fibroblasts using lipofectamine (GIBCO-BRL, Life Technologies, Gaithersburg, MD, USA). Fortyeight hours after transfection the transduced cells were selected by culturing in the presence of 0.8 mg/ml G418 for 2 weeks.
Experimental animals
Mice were bred from the carrier strain C57Bl/6-ByBir-H-2 bm1 gus mps . Normal, carrier, and MPS VII pups were identified by PCR for the mutation. All of the studies were approved by, and carried out according to the guidelines of the Institutional Animal Care and Use Committee.
Fibroblast brain grafts and preparation of tissues
Fibroblasts infected with a vector were injected as described previously. 10 When animals were to be killed, they were deeply anesthetized, the chest cavity was opened, the descending vena cava was ligated and the mice were perfused through the left heart ventricle with PBS until the outflow was clear. For animals processed for enzyme localization and quantitation, the perfusion was continued with 10% formalin containing chloral hydrate, which is the optimal fixative for GUSB activity. The brains were embedded in OTC and 20-mm sections were cut on a cryomicrotome, and sections were adhered to poly-L-lysine-coated glass slides, which were dried and stored at -20°C until assayed.
Generation, transplantation and harvesting of neoorgans
The neo-organs were prepared as described. 8 Briefly, Gore-Tex fibers (a gift from WR Gore Inc., Taos, NM, USA) were coated with collagen, sterilized by UV light, and coated with 10 g/ml recombinant fibroblast growth factor (FGF)-2 (Promega, Madison, WI, USA). The cells were harvested by trypsinization, washed once with PBS, and 5 × 10 6 cells/ml were resuspended in DMEM containing 10% FBS, 5 mM Hepes, 100 g penicillin/streptomycin/fungizone, 1 l (10 g/ml) FGF-2 (Promega), 0.25 l (0.8 mg/ml) epidermal growth factor (Boehringer Mannheim, Mannheim, Germany), and 0.5 ml (3 mg/ml) collagen in a dish with evenly separated fibers. After incubation at 37°C for 30 min in the presence of 5% CO 2 , two volumes of medium were added and the incubation was continued for 2 days, by which time the neo-organ contracted into a semi-solid gel. The neoorgans were transplanted subcutaneously through surgically prepared bilateral 1 cm incisions on each side of the back. Through a single incision, one neo-organ was inserted by blunt dissection subcutaneously rostrally and one caudally, and the incision closed with a surgical clip. This resulted in four individual grafts in each mouse that were physically separated subcutaneously. At various time-points after surgery, individual neo-organs were identified by encapsulation and removed, single cell suspensions were made by mincing and dispase digestion, and the explant cultures were evaluated for enzyme expression.
Enzyme activity measurements
Quantitative enzyme activities were measured as described and are reported as nmol substrate cleaved per hour per mg of total protein. Cultured cells were harvested by trypsinization and washed once with PBS. The cell pellets or tissue pieces were resuspended in a lysis buffer (0.9% NaCl, 0.2% Triton X-100 in water) and vortexed vigorously, followed by three cycles of freeze-thaw. After centrifugation at 13 000 g for 4 min in a microcentrifuge, the supernatants were collected for enzyme assays. Enzyme activities were measured fluorometrically following incubation of 100 l of sample (diluted with the lysis buffer if necessary) at 37°C for 1 h with 100 l of substrate (10 mM 4-methylumbelliferyl ␤-D-glucuronide, Sigma, St Louis, MO, USA). The reactions were stopped by adding 1.8 ml of 0.2 M glycine-carbonate, pH 10.5. The free fluorescence was read at excitation 365 nm and emission 448 nm on an F-1200 fluorescence spectrophotometer (Hitachi, Japan). The amount of substrate cleaved was calculated from a standard curve established using 4-methylumbelliferone (Sigma) and expressed as nmol/h/mg for enzymatic activity in cell lysate or nmol/h/ml in the medium. Duplicate measurements were made on each sample, and all assays were run with triplicate samples for calculation of average and standard error of the mean values. Protein concentration was determined using the Coumassie dye binding assay (BioRad Laboratories, Hercules, CA, USA). Histochemical
